Charles K. Ruck

Charles Ruck's representative experience includes advising:

Special Committees

• Committee of Independent Directors of T-Mobile US in its US$146 billion merger between T-Mobile US and Sprint.
• Independent Directors of the Board of First Data Corporation in its US$22 billion acquisition by Fiserv.
• Special Committee of the Board of Tesla Inc. in its evaluation of any going-private proposals.
• Special Committee of Griffin-American Healthcare REIT II in its US$4 billion acquisition by NorthStar Realty Finance Corp.
• Special Committee of the Board of Switch in its US$11 billion acquisition by DigitalBridge Investment and IFM.

Shareholder Activism

• Allergan in a groundbreaking takeover attempt orchestrated with activist shareholder Bill Ackman and Pershing Square.
• Advising on numerous activist campaigns, including those orchestrated by Carl Ichan at Trian and Dan Loeb at Third Point.
• Coordinating strategy for over 100 shareholder proxy proposals on topics from proxy access to shareholder written consents.

Mergers & Acquisitions

• Allergan in several transactions, including its US$40.5 billion sale of Global Generic Pharmaceuticals Business to Teva and US$28 billion acquisition of Forest Laboratories.
• ST Telemedia in CenturyLink’s US$34 billion acquisition of Level 3 Communications, Inc.
• Raptor Pharmaceuticals in its US$800 million acquisition by Horizon Pharma plc.
• Starbucks Corporation in its US$913 million acquisition of Starbucks Coffee Japan, Ltd.
• Spirit Realty Capital, Inc. in its US$7.4 billion merger with Cole Credit Property Trust II.

Capital Markets

• Representing issuers and underwriters in numerous public and private offerings, including Allergan, Amgen, and Broadcom.
• Regularly working with top investment banks in their roles as financial advisors, underwriters, and placement agents.